Biostock: Chordate comments on Q4 and case report

Kalqyl: Chordate Medical Initial take

Biostock: Chordate Medical launches the trademark Ozilia

Biostock: Chordate Medical’s migraine treatment gets attention at congress

Biostock interview: Dr Hoffmann presented Chordate Medical’s results in the US


Biostock: Chordate presents study results for the American Headache Society

Biostock: Market update Chordate Medical: “We have a favourable position”

Biostock: Chordate makes progress in Italy, China and Saudi Arabia

Analyst Group: Kommentar på Chordate Medicals Q4-rapport

BioStock: Chordate: “Vi satsar i stort sett allt på marknaden”